focus -WSS

focus

author：explore 2025-10-01 17:34:53 - browse：94288

Senate Health, Education, Labor, and Pensions Chair Sen. Bernie Sanders, I-Vt., points toward a poster detailing what he said the U.S. versus the "Rest of the World" spends on prescription drugs, during a hearing to examine the cost of prescription drugs. -- health policy coverage — Sen. Bernie Sanders (I-Vt.) raises his hand at a Thursday hearing on Capitol Hill in Washington to examine the cost of prescription drugs. Jacquelyn Martin/AP

WASHINGTON — Call it Sen. Bernie Sanders’ prescription drug pricing theater.

The hearing, featuring Merck CEO Robert Davis, Johnson & Johnson CEO Joaquin Duato, and Bristol Myers Squibb CEO Chris Boerner, was designed to draw public interest, and in that respect, it worked. The wood-paneled hearing room in a Senate office building was standing room only, with an overflow room prepared. Photographers flocked for photos as Sanders shook hands with each executive, standard practice before such hearings begin.

Sanders’ staff got an arm workout switching out foam boards behind the chairman’s head, illustrating how the drug companies called to testify make more revenue from the United States on certain medications than the rest of the world combined.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Harvard's David Sinclair gets blowback over aging

WSS

Harvard's David Sinclair gets blowback over aging

CDC recommends rationing of RSV shot due to shortages

FDA has safety concerns on CRISPR

For AI in health care standards, federal regulators join with industry group

First Opinion Podcast: How to protect health care in times of war

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

explore

focus

focus

New air purifier tech could be key to improving indoor air quality

Traditional Chinese medicine benefits explored in new JAMA study

As demand for Covid shots wanes, Moderna seeks its next success

State of the Union pitch: Bigger Medicare drug price negotiations

Guidelines to prevent youth baseball injuries need more muscle

Physician subsidies by hospitals soar in wake of No Surprises Act

23andMe had bad news about my health. I wish a person had delivered it

The public health thinking behind the CDC’s new Covid guidance

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare drug price negotiation hearing pits pharma v Biden admin

hotspot

For AI in health care standards, federal regulators join with industry group

Immune cells and nerve overgrowth may explain recurring UTI pain

First Opinion Podcast: How to protect health care in times of war

First Opinion Podcast: How to protect health care in times of war

Medtronic CEO on promising devices for diabetes, hypertension

The pink breast cancer awareness ribbon needs a redesign

entertainment

focus

Wikipedia

focus